Neutrophil membrane‐based drug delivery, leveraging inflammatory chemotaxis, holds promise for treating Fn‐infiltrated colorectal cancer.[36, 37] Furthermore, our results demonstrated that Fn gavage promoted the expression of adhesion molecules, which provided powerful support for Neutrophil membrane‐based drug delivery to effectively target and bind to tumor cells. The gene discussed is FN1; the disease is neoplasm.